6-bromo-8-fluoro-1,4-dihydroquinazolin-4-one, 98%, 5g

ethyl 4-{[1,1'-biphenyl]-4-yl}-2,4-dioxobutanoate, 95.0%, 10g

cyclopentyl 2-(thiomorpholinomethyl)phenyl ketone, 97.0%, 1g

2-(O-tolyl)propan-2-amine, 95%, 500mg

3-(Methoxymethyl)cyclobutanone, 98%, 100mg

6-(Hydroxymethyl)nicotinonitrile, 95.0%, 500mg

3,3-Difluorocyclobutyl benzoate, 95.0%, 500mg

1,1-Dimethylethyl N-[[[(2,4-dimethoxyphenyl)methyl]amino]thioxomethyl]carbamate, 98%, 1g

1-Aminopyridin-1-ium 2,4,6-trimethylbenzene-1-sulfonate, 95%, 5g

8-Fluoro-4-hydroxy-2-(trifluoromethyl)quinoline, 97.0%, 10g

Plan phase S40x/0.65 infinity corrected objective

2-Methylnicotinic acid, 98.0%, 500g

4-Bromo-1H-indole-3-carbonitrile, 95.0%, 5g